Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro
- 31 July 1991
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 16 (1), 11-16
- https://doi.org/10.1016/0166-3542(91)90054-u
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis and antiviral activity of the nucleotide analog (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cystosineJournal of Medicinal Chemistry, 1989
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Recombinant Human Interferon- Inhibits Adenovirus Multiplication without Modifying Viral PenetrationJournal of General Virology, 1987
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- Adenovirus type 8 keratoconjunctivitis – an outbreak and its treatment with topical human fibroblast interferonEpidemiology and Infection, 1986
- 2′-nor-cGMP: A seco-cyclic nucleotide with powerful anti-DNA-viral activityBiochemical and Biophysical Research Communications, 1985
- Interferon Treatment of Adenoviral ConjunctivitisAmerican Journal of Ophthalmology, 1984
- Comparative Efficacy of Antiberpes Drugs Against Various Strains of Varicella-Zoster VirusThe Journal of Infectious Diseases, 1983
- Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19.British Journal of Ophthalmology, 1977
- Treatment of adenovirus infection of the eye with 5-iodo-2'-deoxyuridine. A double-blind trial.British Journal of Ophthalmology, 1969